HER-2 Positive Gastric Cancer
1 competing product in clinical development for HER-2 Positive Gastric Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab + Capecitabine + Cisplatin | Celltrion | Phase 2 | UNKNOWN | 52 |